S2 E2.3 - Partners and enablers Necessary to Help Drive Broader NAFLD and Non-Communicable Disease
Send us a text The Surfers end this episode by discussing the need for public education to create the awareness necessary for change. This conversation covers a broad range of topics -- public health needs in different parts of the world, non-communicable disease, public awareness -- but ends in a discussion on the need for public and industry sponsorship to support the broad scale of education needed to create the level of public awareness necessary to change behavior.
16 Jan 202113min
S2 E2.2 - Economic and Patient Motivation Costs and Value of telemedicine and New Non-Invasive Diagnostic Testing
Send us a text Evaluating the economic and patient-motivating value of enhanced telemedicine and mobile non-invasive testing technologies in improving NAFLD diagnosis and lowering rates of non-communicable disease. The Surfers and our guest Dr. Manal Abdelmalek consider the economic costs and value of enhanced telemedicine and mobile “de-liver” testing technology and then move on to consider critical success factors in making these innovations patient-friendly and motivating patients to tak...
16 Jan 202115min
S2 E2.1 - Innovations in Telemedicine and Mobile Technology can improve care for NAFLD patients
Send us a text Innovations in Telemedicine and Mobile Technologies are already changing patient care in ways that will remain and expand in the "New Normal" after the COVID-19 pandemic is less urgent. Our guest, Dr. Manal Abdelmalek discusses how a rough week in patient-management led her to envision innovative ways to incorporate telemedicine and mobile technologies such as FibroScan and non-invasive blood tests like NIS-4, ELF, and FIB-4, into patient care. Stephen Harrison and Louise Camp...
16 Jan 202120min
S2 E2 — How COVID-19 is changing patient management and clinical trials
Send us a text Manal Abdelmalek joins the Surfers to describe long-term changes in patient management that improved diagnostic and telecommunication technologies can drive in response to new COVID-19 induced challenges. How must we adapt to the changes in patient management caused by COVID-19? The Surfers, spurred by creative ideas from guest Manal Abdelmalek, think about ways to re-engineer patient communication and treatment, including innovations in patient-management and out-of-office di...
14 Jan 202150min
S2 E1.3 - Challenges and Big Ideas for NAFLD/NASH Patient Diagnosis and Treatment in the Post-Second Wave World
Send us a text Question: If NALFD patients have poorer COVID-19 prognoses, how can we use this fact to drive broader population-based screening? This conversation asks a two-part question: How do we motivate primary care treaters and specialists who treat metabolic syndromes to manage NAFLD more aggressively? The conversation considers education and telemedicine in this context and then turns to two very ambitious concepts. One of these deals with screening, the other with treatment before a...
9 Jan 202123min
S2 E1.2 Successfully Managing Clinical Trials during COVID-19's Second Wave
Send us a text The COVID-19 conversation continues with the group focusing on challenges in clinical trial execution and how innovative logistics and consistent education can lessen or overcome them. In this conversation, the group starts by discussing the significant number of patients who could benefit from NAFLD or NASH therapy centered around defatting the liver through medications and behavioral support and proceeds to address ways to manage these issues in a pandemic for a disease with...
9 Jan 202121min
S2 E1.1 - How Recent COVID-19 News Affects NAFLD and NASH Patients
Send us a text Manal Abdelmalek joins the Surfers to consider the three most important COVID-19 stories today. The conversation focuses on the British variant, the new vaccines, and the physical and emotional toll the pandemic continues to take on front-line physicians and other healthcare workers. Stephen and Manal each have a sibling who works as an ER physician and they provide heart-wrenching stories on how tough the front lines are. Louise discusses how Britain is reacting to government...
9 Jan 202123min
S2 E1 - How Will COVID-19 Affect the Fatty Liver Community in 2021?
Send us a text Manal Abdelmalek joins the Surfers to discuss how recent COVID-19 news might affect Fatty Liver patients and what the medical profession and BioPharma companies can do to support patients better during this dangerous phase of the pandemic. Manal Abdelmalek joins the Surfers to discuss the implications of the new British COVID-19 variant, availability of the Pfizer/BioNTech and Moderna vaccines and impact of social distancing on patients with Fatty Liver Disease. The discussion...
7 Jan 20211h 10min
